Suchergebnisse - "Bersanelli, Melissa"

PubPharm (205)

1

Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27

enthalten in: Clinical genitourinary cancer | 2024

von Stellato, M. | Buti, S. | Maruzzo, M. | +19

2

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Maiorano, B. | Di Maio, M. | Cerbone, L. | +104

3

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

4

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

enthalten in: Human vaccines & immunotherapeutics | 2023

von Bersanelli, M. | Rebuzzi, S. | Roviello, G. | +3

5

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors : results from the prospective PROVIDENCE study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Bersanelli, M. | Cortellini, A. | Leonetti, A. | +25

6

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors : An INVIDIa-2 study sub-analysis

enthalten in: iScience | 2023

von Anpalakhan, S. | Signori, A. | Cortellini, A. | +44

7

Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors : Impact on Efficacy and Survival

enthalten in: Cancers | 2023

von Choucair, K. | Nebhan, C. | Cortellini, A. | +23

8

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab

enthalten in: Immunotherapy | 2023

von Taguchi, S. | Kawai, T. | Buti, S. | +26

9

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study

enthalten in: Cancer immunology immunotherapy | 2023

von Bersanelli, M. | Cortellini, A. | Leonetti, A. | +25

10

The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Perrone, F. | Favari, E. | Maglietta, G. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]